Congo vs Fiji: Average cost of multi drug-resistant tuberculosis treatment
Congo
726 constant 2022 US$
in 2024
Fiji
700 constant 2022 US$
in 2022
Congo rank
66th
Fiji rank
68th
Average cost of multi drug-resistant tuberculosis treatment over time
- Congo
- Fiji
How they compare
Congo currently reports 726 constant 2022 US$ against 700 constant 2022 US$ in Fiji, a difference of 26 constant 2022 US$.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Fiji ahead.
Congo ranks 66th and Fiji ranks 68th of 92 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,793 constant 2022 US$ | 4,233 constant 2022 US$ | 2,441 constant 2022 US$ | Fiji |
| 2020s | 635.67 constant 2022 US$ | 4,233 constant 2022 US$ | 3,598 constant 2022 US$ | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Congo or Fiji?
- Congo, at 726 constant 2022 US$ against 700 constant 2022 US$ in Fiji as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Congo and Fiji?
- 26 constant 2022 US$, with Congo ahead.
- How many years of comparable data are there for Congo and Fiji?
- 6 years are reported by both, from 2017 to 2022.
- How do Congo and Fiji rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Congo ranks 66th and Fiji ranks 68th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.